- Q1 2024 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 08, 2024$13.61 (-20.92%)Earnings
- Q4 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptMar 01, 2024$18.69 (+11.92%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 14, 2023$5.36 (+9.84%)Earnings
- Q2 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 11, 2023$5.55 (-9.90%)Earnings
- Q1 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 09, 2023$9.23 (+36.34%)Earnings
- Q4 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptMar 31, 2023$5.01 (+52.28%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Y-mAbs Therapeutics Inc To Host Annual Research and Development Day TranscriptDec 14, 2022
- Q3 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 08, 2022$3.89 (+16.12%)Earnings
- Q2 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 09, 2022$17.89 (-4.33%)Earnings
- Q1 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 10, 2022$10.03 (+22.02%)Earnings
- Q4 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptFeb 25, 2022$8.91 (+11.24%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Y-mAbs Therapeutics Inc Research And Development Day (Virtual) TranscriptDec 15, 2021
- Q3 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 05, 2021$22.23 (-6.32%)Earnings
- Y-mAbs Therapeutics Inc to Host Key Opinion Leader Webinar on DANYELZA® - Conference Call TranscriptSep 23, 2021
- Q2 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 06, 2021$29.25 (-21.60%)Earnings
- Q1 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 07, 2021$34.2 (+19.37%)Earnings
- Full Year 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptFeb 26, 2021$35.17 (+4.42%)Earnings
- Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptDec 16, 2020
- Q3 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptNov 06, 2020$47.32 (-2.83%)Earnings
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptOct 06, 2020
- Q2 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptAug 07, 2020$38.03 (-4.33%)Earnings
- Y-mAbs Therapeutics, Inc Annual Shareholders Meeting TranscriptJun 11, 2020
- Q1 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptMay 08, 2020$39.84 (+12.51%)Earnings
- Q4 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptMar 12, 2020$19.66 (-14.45%)Earnings
- Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptDec 11, 2019
- Q3 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptNov 13, 2019$28.68 (+0.46%)Earnings
- Q2 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptAug 14, 2019$26.16 (+1.32%)Earnings
Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference Transcript
Okay. We'll go ahead and get started. So welcome, everybody, to the Wednesday afternoon session of the 2020 JPMorgan Health Care Conference. My name's Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team.
Our next presenting company is Y-mAbs Therapeutics, and presenting on behalf of the company, we have CEO, Claus Møller. Claus?
¸ -
Thank you very much, Anupam, and thank you, everybody, for coming and listening to Y-mAbs' presentation. Let's jump right into it.
Our mission is to become the world leader in developing better and safer antibody-based pediatric oncology products addressing key unmet medical needs. We have a lot of passion behind this company. Our Chairman, Thomas Gad, had the unfortunate experience to have a daughter that went through the treatment with both our lead compound. Fortunately, she
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)